Azd-1222/tozinameranGeneralised morphea: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1930卷 / 1期

关键词：

D O I：

10.1007/s40278-022-26386-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：123 / 123

相关论文

共 50 条

[1] AZD-1222/tozinameranAnaphylaxis: 4 case reports
Reactions Weekly, 2024, 2023 (1) : 74 - 74
[2] Azd-1222/tozinameranPrimary podocytopathy: 4 case reports
Reactions Weekly, 2022, 1908 (1) : 109 - 109
[3] AZD-1222/tozinameranGeneralised oedema, pseudothrombocytopenia and vaccine failure: case report
Reactions Weekly, 2022, 1914 (1) : 112 - 112
[4] AZD-1222/tozinameranPolymyalgia rheumatica: 4 case reports
Reactions Weekly, 2022, 1911 (1) : 92 - 92
[5] Azd-1222/tozinameranHeadache: 5 case reports
Reactions Weekly, 2023, 1980 (1) : 78 - 78
[6] Azd-1222/tozinameranDeath: 2 case reports
Reactions Weekly, 2023, 1940 (1) : 103 - 103
[7] Azd-1222/elasomeranHyperthyroidism: 3 case reports
Reactions Weekly, 2023, 1947 (1) : 97 - 97
[8] AZD-1222/tozinameranVarious toxicities: 3 case reports
Reactions Weekly, 2022, 1897 (1) : 85 - 85
[9] AZD-1222/tozinameranSubacute thyroiditis: 2 case reports
Reactions Weekly, 2022, 1893 (1) : 70 - 70
[10] AZD-1222/elasomeran/tozinameranMinimal change disease: 4 case reports
Reactions Weekly, 2022, 1927 (1) : 123 - 123

← 1 2 3 4 5 →